KYMR — Kymera Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Kymera Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	296	442	407	375	489
Net Total Accounts Receivable
Net Total Receivables	1.43	0.135	2.54	18.8	0.947
Prepaid Expenses
Total Current Assets	302	451	419	405	510
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20.7	21.3	22.2	101	97.9
Long Term Investments
Other Long Term Assets
Total Assets	487	606	603	576	978
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	111	92.5	71.3	85.7	67.8
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	203	146	113	181	142
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	284	460	490	395	836
Total Liabilities & Shareholders' Equity	487	606	603	576	978
Total Common Shares Outstanding